Ziprasidone Mesylate
Medicare prescription drug cost, prescriptions and prescribers, 2024
$489K
Medicare cost, 2024
$489K
Medicare cost, 2024
Medicare drug plans spent $489,409 on Ziprasidone Mesylate in 2024, for 2,733 prescriptions and refills filled by 1,264 patients. Florida accounts for the most spending ($67,224, 14% of the total).
Medicare cost, 2024
$489K
-2.4% from 2023
Prescriptions
2,733
$179.07 per claim
Patients
1,264
823 prescribers
Total spending, 2024
$489K
$386.92 per patient
Questions and answers
How much does Medicare spend on Ziprasidone Mesylate?
Medicare prescription drug plans paid $489K for Ziprasidone Mesylate in 2024, for 2,733 prescriptions and refills to 1,264 patients (down 2.4% from 2023). The average cost per claim was $179.07.
Which state spends the most on Ziprasidone Mesylate?
Florida had the highest Medicare cost for Ziprasidone Mesylate in 2024: $67K for 168 claims, followed by Georgia ($52K).
Who prescribes Ziprasidone Mesylate the most?
Sharon D Blue, nurse practitioner in Tampa, FL, had the highest Medicare cost for Ziprasidone Mesylate in 2024: 18 claims costing $20K.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Ziprasidone Mesylate was $489K in 2024, after a high of $503K in 2023.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Ziprasidone Mesylate, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Sharon D Blue Tampa, FL | Nurse Practitioner | 18 | Under 11 | $20K |
| Clyde O Green Macon, GA | Family Practice | 46 | Under 11 | $19K |
| Dolores A Stefanski Tampa, FL | Nurse Practitioner | 33 | 15 | $14K |
| Scott M Galenski Maumee, OH | Certified Clinical Nurse Specialist | 45 | 17 | $12K |
| Julie L Waterbury Saint Louis, MO | Nurse Practitioner | 41 | 30 | $12K |
| Cristina E Roberts Oakland Park, FL | Nurse Practitioner | 23 | 17 | $9,844 |
| Pat F Bass Shreveport, LA | Internal Medicine | 38 | 12 | $9,556 |
| Michael T Peacock Eastman, GA | Internal Medicine | 26 | 19 | $7,285 |
| Brooke Jones Richmond, VA | Registered Nurse | 23 | Under 11 | $5,594 |
| Larry R Levine Dunedin, FL | General Practice | 13 | Under 11 | $5,469 |
| Robert Otto Lenexa, KS | Nurse Practitioner | 17 | Under 11 | $5,405 |
| David Desantis Richmond, IN | Family Practice | 25 | Under 11 | $5,242 |
| James V Rider Winchester, KS | Family Practice | 19 | Under 11 | $4,415 |
| Rex B Cabaltica West Columbia, SC | Family Practice | 12 | Under 11 | $3,769 |
| Samuel P Walker Sr. Luverne, AL | Emergency Medicine | 16 | Under 11 | $3,754 |
| Annette G Tarpley Roanoke, VA | Nurse Practitioner | 15 | Under 11 | $3,618 |
| Julio E Iglesias Winnfield, LA | General Surgery | 18 | Under 11 | $3,583 |
| Ruthann Allison Florence, AL | Nurse Practitioner | 17 | Under 11 | $3,449 |
| Daniel A Welt Toledo, OH | Family Practice | 12 | Under 11 | $3,218 |
| Robert W Baker Los Angeles, CA | Nurse Practitioner | 14 | Under 11 | $2,861 |
| Gilbert M Simas Los Angeles, CA | Psychiatry | 15 | Under 11 | $2,528 |
| Lisa Caffee Royal Oak, MI | Nurse Practitioner | 11 | Under 11 | $2,150 |
| Mazen I Madhoun Salem, VA | Family Practice | 25 | 12 | $2,029 |
| Mohammad A Alsoub Dickson, TN | Pulmonary Disease | 14 | Under 11 | $1,962 |
| Sarabjit S Sandhu Newport Beach, CA | Psychiatry | 11 | Under 11 | $1,920 |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 774 | 2,529 | 1,217 | $450K |
| 2023 | 846 | 2,842 | 1,294 | $501K |
| 2024 | 823 | 2,733 | 1,264 | $489K |
Makers, 2024
Spending by manufacturer as listed in the spending data
Medicaid spending by quarter
Amount reimbursed by state Medicaid programs, all states
Amount reimbursed
Codes
- National drug codes (packages)
- 10
- RxNorm concept IDs
- 351223
- Application numbers
- ANDA211908, ANDA216091, ANDA217595
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through August 2026, 136 side-effect reports named ziprasidone mesylate (reports from 2011 on). 128 of them (94.1%) were serious, 32 named a death and 37 named a hospital stay. The reactions named most often were drug ineffective, suicide attempt and anosognosia. 81 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
136
10 in 2025 (-9.1% from 2024)
Serious
94.1%
128 reports
Deaths named
32
23.5% of reports
Hospital stays
37
27.2% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Ziprasidone Mesylate?
136 reports from 2011 through August 2026 named ziprasidone mesylate. 128 of them (94.1%) were serious, 32 named a death and 37 named a hospital stay.
What are the most reported side effects of Ziprasidone Mesylate?
113 reports named drug ineffective, the reaction named most often, followed by suicide attempt (113) and anosognosia (89). In the last 5 years the reaction named most often was suicide attempt (63 reports). A report can name several reactions.
How many side-effect reports named Ziprasidone Mesylate in 2025?
10 reports were received in 2025 (-9.1% from 2024). 2026 so far: 5 reports through August 2026, and more keep arriving late.
Do side-effect reports prove that Ziprasidone Mesylate caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Ziprasidone Mesylate caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
- Other Medicare drug pages with ziprasidone mesylate: Geodon
- Drug approvals (3 approvals on file for ziprasidone mesylate) · Clinical trials · Medicare drug spending
Side-effect reports from official public data, counted per active ingredient (ziprasidone mesylate) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.